About the Event

Experts in the field of viral respiratory infections will discuss current and future therapeutics. The topics include respiratory syncytial virus (RSV) epidemiology and treatment, cytomegalovirus (CMV) therapies and respiratory pathogen vaccine development.

Register free for light dinner, face-to-face discussion, expert-delivered seminar, and take advantage of the Q&A session to get answers to your specific questions from our expert panel. Zoom link for those attending online will also be provided.

Thursday 27 October 2022

Brisbane, Australia 6:00pm AEST

Melbourne Australia 7:00pm AEDT

Auckland, New Zealand 9:00pm NZST

Malaysia Time, MYT 4:00pm MYT

Jakarta, Indonesia 3:00pm WIB

Nîmes, France 10:00am CEST

London, United Kingdom 9:00am BST

Preliminary Program

5.30 pm AEST (Brisbane) Dinner and Registrations

6.00 pm AEST (Brisbane) Welcome and Introductions

Dr Suzanne Parker, The University of Queensland

Moderator: Dr Andrew Burke

6.05 - 6.25 pm AEST RSV - Epidemiology and Future Treatment Strategies

Associate Professor Chris Blyth, University of Western Australia

6.30 - 6.50 pm AEST Current and Future Therapies for CMV Disease
Dr Michelle Young, ID Physician PeterMac Institute, Melbourne

6.55 - 7.15 pm AEST Successes and Pitfalls in Respiratory Pathogen Vaccine Development

Prof Michael Nissen, Paediatric ID Physician and Clinical Microbiologist and Director of Research, The Prince Charles Hospital

7.20pm AEST Questions & Answers7.45pm AEST Close

Venue

RBWH Education Centre, Block 1
Cnr Bowen Bridge Rd & Butterfield St
Royal Brisbane & Women's Hospital
Herston, Queensland

For more information, visit the website.

---